Dedicated to investigational stem cell research
“We support continued scientific research into stem cell and regenerative medicine.”
The statements on this website have not been evaluated by the U.S. Food and Drug Administration (FDA). Our cellular and exosome products are investigational, are not FDA-approved, and are not intended to diagnose, treat, cure, or prevent any disease. The information provided here is for educational purposes only and is not medical advice.
BHI Therapeutic Sciences Jamaica supports scientific research and education in stem cell and regenerative medicine. We engage in collaborative relationships with leading institutions, scientists, and physicians across the globe.
Our research uses only cells from a participant’s own body (autologous) or from umbilical cord donors who have passed a multiple-step screening and testing process. We do not use embryonic stem cells, nor will we ever.
BHI Therapeutic Sciences Jamaica has US board-certified physicians on staff. Our Scientific Advisory Board and Ethics Committee oversee research protocols to support high standards of research conduct and participant safety.
BHI Therapeutic Sciences Jamaica supports investigational stem cell research and does not offer its cellular products as a treatment for any disease.
Many allogeneic stem cell products are being studied in humans for a wide range of medical conditions; their safety and effectiveness are still being evaluated. The human Umbilical Cord Blood products that have been evaluated in clinical studies conducted by BHITS were collected in accordance with Good Tissue Practice. BHITS seeks to comply with the regulatory requirements of each country in which it conducts research. A study involving human umbilical cord blood cells has been registered on ClinicalTrials.gov (Identifier: NCT03735277). There is no IND in effect, and registration on ClinicalTrials.gov does not indicate FDA approval or endorsement. Our cellular products are investigational and are not approved by the FDA for any use. In specific markets around the world, there is both the unmet need and the financial opportunity to establish medical facilities that provide the same quality as that found in the best facilities in the United States. BHITS intends to support high-quality cellular research through centers it may establish in other countries. BHITS has recruited top medical professionals and scientific advisors, and regulatory specialists to help design research protocols and monitor participant safety, to collect and analyze outcome data for potential submission to the FDA and EMA, and to innovate patent procedures, devices, and therapies for future commercialization.
Stem cells are being studied for a wide range of conditions. Stem cells are essentially “blank slate” cells that possess the remarkable potential to differentiate to any one of the billions of cells that form the diverse tissues of the human body. In addition, stem cells have the power to divide virtually without limits and develop into specialized cells, which is why they are being studied in regenerative medicine research.
Stem cell research is an active area of regenerative medicine, and stem cells are being studied in clinical research for a variety of health conditions.
Our research team is happy to answer questions about our research studies. Our cellular products are investigational and are not approved to diagnose, treat, cure, or prevent any disease.
BHI Therapeutic Sciences Jamaica follows quality-control procedures for the cells used in its research. BHI Therapeutic Sciences stem cells are tested for sterility, infectious diseases and have high cell count and viability. Every unit of Human Umbilical Cord Blood Mononuclear Cells and Human Umbilical Cord Mesenchymal Stem Cells has the Cell Quality Certificate with the following information: Virus Tests (Hepatitis B virus, Hepatitis C virus, Human Immunodeficiency virus and Treponema pallidum), Microbiological Tests (Bacteria, Fungus, Mycoplasma, Endotoxin), the cell count and viability.
Human Umbilical Cord Blood Mononuclear Cells
Human Umbilical Cord Mesenchymal Stem Cells
BHI Therapeutic Sciences Jamaica conducts investigational stem cell research under institutional review board oversight. Jamaica is the largest English-speaking island in the Caribbean. Our cellular products are investigational and are not approved by the U.S. FDA.
BHI Jamaica is located in Montego Bay.
The facility is designed to follow Good Manufacturing Practice (GMP) standards.
Research participants can stay on site or in nearby hotels.
